Hepatitis C Treatment Study in Myanmar

NCT03158857 · clinicaltrials.gov ↗

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Long local IRB process to meet with the treatment deadline

Conditions

Hepatitis C

Interventions

DRUG: Sofosbuvir 400 mg

Sponsor

Myanmar Oxford Clinical Research Unit

Collaborators

[object Object]
[object Object]